Lifeward Ltd (LFWD) Stock Price, Quote & News

Latest News on LFWD

Jan 13, 2025, 8:30 AM EST - 4 days ago

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Jan 13, 2025, 7:45 AM EST - 4 days ago

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Jan 8, 2025, 4:15 PM EST - 9 days ago

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 7, 2025, 8:05 AM EST - 10 days ago

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 27, 2024, 5:49 PM EST - 21 days ago

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Nov 19, 2024, 8:30 AM EST - 2 months ago

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Nov 12, 2024, 11:30 AM EST - 2 months ago

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:00 AM EST - 2 months ago

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 4:38 PM EST - 2 months ago

Lifeward to Report Third Quarter Financial Results on November 12, 2024

Oct 24, 2024, 4:30 PM EDT - 3 months ago

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

Sep 24, 2024, 5:00 PM EDT - 4 months ago

Lifeward Launches Direct Sales of AlterG Product Line in Germany

Sep 12, 2024, 8:30 AM EDT - 4 months ago

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

Sep 10, 2024, 8:30 AM EDT - 4 months ago

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

Sep 5, 2024, 8:30 AM EDT - 4 months ago

Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury

Sep 4, 2024, 4:15 PM EDT - 4 months ago

Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 15, 2024, 1:07 PM EDT - 5 months ago

ReWalk Robotics Ltd. (LFWD) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:15 PM EDT - 5 months ago

Lifeward to Report Second Quarter Financial Results on August 15, 2024

Jul 2, 2024, 4:30 PM EDT - 7 months ago

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

Jun 26, 2024, 8:30 AM EDT - 7 months ago

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

Jun 4, 2024, 4:30 PM EDT - 8 months ago

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

May 15, 2024, 1:06 PM EDT - 8 months ago

ReWalk Robotics Ltd. (LFWD) Q1 2024 Earnings Call Transcript

May 15, 2024, 8:00 AM EDT - 8 months ago

Lifeward Reports First Quarter 2024 Financial Results

May 7, 2024, 4:30 PM EDT - 9 months ago

Lifeward to Report First Quarter Financial Results on May 15, 2024

Apr 19, 2024, 8:30 AM EDT - 9 months ago

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

Apr 12, 2024, 8:30 AM EDT - 10 months ago

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

Apr 1, 2024, 4:30 PM EDT - 10 months ago

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

Mar 22, 2024, 8:30 AM EDT - 10 months ago

VA STAND Act introduced in the United States Senate

Mar 13, 2024, 11:45 AM EDT - 11 months ago

Lifeward Announces Reverse Share Split

Mar 8, 2024, 8:30 AM EST - 11 months ago

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Mar 1, 2024, 8:45 AM EST - 11 months ago

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be c

Feb 27, 2024, 1:53 PM EST - 11 months ago

ReWalk Robotics Ltd. (LFWD) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 8:00 AM EST - 11 months ago

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 20, 2024, 8:30 AM EST - 11 months ago

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

Jan 29, 2024, 8:00 AM EST - 1 year ago

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

Jan 12, 2024, 8:30 AM EST - 1 year ago

ReWalk Robotics Expands Direct Sales Coverage to Canada

Jan 11, 2024, 5:00 PM EST - 1 year ago

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

Jan 5, 2024, 8:00 AM EST - 1 year ago

First ReWalk Personal Exoskeleton Claim Paid by Medicare

Nov 30, 2023, 4:45 PM EST - 1 year ago

ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting

Nov 28, 2023, 8:00 AM EST - 1 year ago

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

Nov 14, 2023, 12:08 PM EST - 1 year ago

ReWalk Robotics Ltd. (RWLK) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 8:06 AM EST - 1 year ago

ReWalk Robotics Reports Third Quarter 2023 Financial Results

Nov 10, 2023, 8:30 AM EST - 1 year ago

New Bill Facilitates Veteran Access to Powered Exoskeletons

Nov 7, 2023, 7:40 AM EST - 1 year ago

ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023

Nov 2, 2023, 8:00 AM EDT - 1 year ago

Medicare Coverage Solidified for ReWalk Personal Exoskeleton

Oct 18, 2023, 8:30 AM EDT - 1 year ago

ReWalk Robotics Exhibits at the GITEX GLOBAL Intelligent Connectivity / AI Pavilion

Sep 20, 2023, 8:00 AM EDT - 1 year ago

ReWalk Robotics Offers Thanks to Former Director for His Loyal Service and Valuable Contributions

Sep 6, 2023, 8:00 AM EDT - 1 year ago

ReWalk Robotics Ltd. to Present Virtually at H.C.

Sep 5, 2023, 8:30 AM EDT - 1 year ago

ReWalk Robotics Announces Additional Change to Board of Directors

Aug 11, 2023, 4:15 PM EDT - 1 year ago

ReWalk Robotics Announces Closing of Acquisition of AlterG

Aug 11, 2023, 10:59 AM EDT - 1 year ago

Market Cap	15.94M
Revenue (ttm)	13.85M
Net Income (ttm)	-22.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-159.78%
Debt to Equity Ratio	0.00

Volume	397,600
Avg Vol	302,122
Day's Range	N/A - N/A
Shares Out	8.81M
Stochastic %K	6%
Beta	2.08
Analysts	Strong Sell
Price Target	$13.00